Richard A Waldron's Net Worth
$1.25 Million
Who is Richard A Waldron?
Richard A Waldron has an estimated net worth of $1.25 Million. This is based on reported shares across multiple companies, which include BioAtla, Inc., and SCICLONE PHARMACEUTICALS INC.
SEC CIK
Richard A Waldron's CIK is 0001226961
Past Insider Trading and Trends
2004 was Richard A Waldron's most active year for acquiring shares with 3 total transactions. Richard A Waldron's most active month to acquire stocks was the month of January. 2021 was Richard A Waldron's most active year for disposing of shares, totalling 16 transactions. Richard A Waldron's most active month to dispose stocks was the month of October. 2023 saw Richard A Waldron paying a total of $0.00 for 210,000 shares, this is the most they've acquired in one year. In 2021 Richard A Waldron cashed out on 33,513 shares for a total of $807,160.93, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BioAtla, Inc. (BCAB) Snapshot price: $2.7
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +84.85% | 106K |
—
|
—
| 230.92K |
Feb 15
| |||
Form 4
| -0.77% | -970.00 |
$1.47 | -$1,425.90 | 124.92K |
Oct 31
| |||
Form 4
| -0.76% | -970.00 |
$1.70 | -$1,649.00 | 125.89K |
Sep 30
| |||
Form 4
| -0.76% | -970.00 |
$2.51 | -$2,434.70 | 126.86K |
Aug 31
| |||
Form 4
| -0.75% | -970.00 |
$2.99 | -$2,900.30 | 127.83K |
Jul 31
| |||
Form 4
| -0.77% | -970.00 |
$3.00 | -$2,910.00 | 125.78K |
Jun 30
| |||
Form 4
| -0.76% | -970.00 |
$3.15 | -$3,055.50 | 126.75K |
May 31
| |||
Form 4
| -0.75% | -970.00 |
$3.37 | -$3,268.90 | 127.72K |
Apr 30
| |||
Form 4
| -0.75% | -970.00 |
$2.68 | -$2,599.60 | 128.69K |
Mar 31
| |||
Form 4
| -0.74% | -970.00 |
$2.98 | -$2,890.60 | 129.66K |
Feb 9 - Feb 28
| |||
Form 4
| -0.87% | -1.14K |
$3.79 | -$4,335.76 | 130.63K |
Jan 31
| |||
Form 4
| -0.73% | -970.00 |
$8.25 | -$8,002.50 | 131.77K |
Dec 31
| |||
Form 4
| -0.73% | -970.00 |
$11.01 | -$10,679.70 | 132.74K |
Nov 30
| |||
Form 4
| -0.78% | -970.00 |
$6.89 | -$6,683.30 | 123.71K |
Oct 31
| |||
Form 4
| -0.77% | -970.00 |
$7.70 | -$7,469.00 | 124.68K |
Sep 30
| |||
Form 4
| -0.77% | -970.00 |
$8.71 | -$8,448.70 | 125.65K |
Aug 31
| |||
Form 4
| -0.76% | -970.00 |
$3.40 | -$3,298.00 | 126.62K |
Jul 31
| |||
Form 4
| -0.75% | -970.00 |
$2.85 | -$2,764.50 | 127.59K |
Jun 30
| |||
Form 4
| -0.75% | -970.00 |
$2.41 | -$2,337.70 | 128.56K |
May 31
| |||
Form 4
| -0.74% | -970.00 |
$3.48 | -$3,375.60 | 129.53K |
Apr 30
| |||
Form 4
| -0.74% | -970.00 |
$5.00 | -$4,850.00 | 130.5K |
Mar 31
| |||
Form 4
| -0.73% | -970.00 |
$6.48 | -$6,285.60 | 131.47K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| -0.86% | -1.15K |
$9.56 | -$10,994.00 | 132.44K |
Jan 31
| |||
Form 4
| -1.03% | -1.39K |
$19.63 | -$27,305.33 | 133.08K |
Dec 31
| |||
Form 4
| -9.55% | -14.19K |
$23.48 | -$333,147.62 | 134.47K |
Nov 30 - Dec 2
| |||
Form 4
| -3.00% | -4.60K |
$23.89 | -$109,870.11 | 148.66K |
Nov 29
| |||
Form 4
| -8.00% | -13.33K |
$25.26 | -$336,837.89 | 153.26K |
Nov 22 - Nov 24
| |||
Form 4
| +23.75% | 31.98K |
—
|
—
| 166.59K |
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SCICLONE PHARMACEUTICALS INC No price found
EVP & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
No matching records found |